• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices

Stent Grafts

Endologix picks former Medtronic executive as new CEO

January 7, 2025 By Sean Whooley

Endologix announced today that President and CEO Dr. Matt Thompson intends to step down and take on a new role. Thompson plans to transition into the position of EVP and chief medical officer. As a result, the company appointed Dr. John Liddicoat as its new president and CEO, effective immediately. Richard Mott, Endologix’s board chair, […]

Filed Under: Business/Financial News, Catheters, Endoscopic, Featured, Stent Grafts, Stents, Vascular Tagged With: Endologix, Personnel Moves

Vascular stent graft maker Solaris Endovascular launches to address vascular health challenges

November 13, 2024 By Sean Whooley

Solaris Endovascular today announced its formation to develop solutions for dialysis access and treating peripheral artery disease (PAD). The New Orleans-based company develops technologies to treat and extend the patency of dialysis access fistulae, grafts, and peripheral arteries. It aims to enable patients to lead healthier lives with fewer interventions while lowering costs. Solaris develops […]

Filed Under: Business/Financial News, Drug-Eluting Stents, Endoscopic, Implants, Stent Grafts, Stents, Vascular Tagged With: nitinol, Nitinol Devices & Components, Solaris Endovascular

Endologix reports positive 3-year Detour PAD treatment data

November 6, 2024 By Sean Whooley

Endologix announced the final 36-month results for the DETOUR2 study evaluating its Detour system for treating peripheral arterial disease (PAD). Detour features the EndoCross device and Torus stent grafts. It enables physicians to bypass lesions in the superficial femoral artery by using stents routed through the femoral vein. This restores blood flow to the leg, […]

Filed Under: Catheters, Clinical Trials, Endoscopic, Stent Grafts, Stents, Vascular Tagged With: Endologix

Endospan completes enrollment in aortic arch stent graft study

October 21, 2024 By Sean Whooley

Endospan announced today that it completed enrollment for the primary arm of its TRIOMPHE FDA investigational device exemption (IDE) trial. TRIOMPHE evaluates the safety and efficacy of the Nexus aortic arch stent graft for the treatment of aortic arch disease.  The company previously said it expected to enroll up to 110 patients with a variety […]

Filed Under: Cardiac Implants, Cardiovascular, Clinical Trials, Endoscopic, Implants, Stent Grafts, Stents, Structural Heart, Vascular Tagged With: endospan

Artivion provides $25M loan to Endospan for stent graft system

July 2, 2024 By Sean Whooley

Endospan announced today that entered into an agreement with Artivion for additional loans totaling up to $25 million. Artivion develops, markets and sells a number of products in more than 100 countries around the world. Its offerings land within four groups: aortic stent grafts, surgical sealants, mechanical heart valves and implantable cardiac and vascular human […]

Filed Under: Business/Financial News, Cardiac Implants, Cardiovascular, Clinical Trials, Endoscopic, Funding Roundup, Stent Grafts, Stents, Structural Heart Tagged With: Artivion, endospan

BD initiates IDE trial of stent for treating peripheral arterial disease

March 4, 2024 By Sean Whooley

BD announced today that it enrolled the first patient in a trial of its Vascular Covered Stent for treating peripheral arterial disease (PAD). Franklin Lakes, New Jersey–based BD is evaluating the safety and effectiveness of the stent in its AGILITY FDA investigational device exemption (IDE) trial. The self-expanding, low-profile, polytetrafluoroethylene encapsulated nitinol implant is deployed […]

Filed Under: Clinical Trials, Endoscopic, Stent Grafts, Stents, Vascular Tagged With: BD

Medtronic, Rijnstate enroll first patient in aneurysm repair trial

February 1, 2024 By Sean Whooley

Medtronic , with Rijnstate, announced today that they enrolled the first patient in the Hercules trial comparing abdominal aortic aneurysm repair methods. Hercules compares endosuture aneurysm repair (ESAR) to standard endovascular aneurysm repair (EVAR). It looks at these methods in patients who have an abdominal aortic aneurysm (AAA) with a wide, infrarenal neck diameter. Abdominal aortic aneurysms […]

Filed Under: Clinical Trials, Featured, Stent Grafts, Stents, Vascular Tagged With: Medtronic

FDA approves Gore low-profile balloon-expandable endoprosthesis

January 31, 2024 By Sean Whooley

W.L. Gore & Associates announced today that it received FDA approval for a lower-profile Viabahn VBX balloon-expandable endoprosthesis. FDA approval builds on the company’s proven VBX stent graft for treating complex vascular disease. The company says it offers the longest balloon-expandable stent on the market (79 mm) and the widest range of stent diameter adjustability. […]

Filed Under: Stent Grafts, Stents, Vascular Tagged With: W.L. Gore & Associates

Gore enrolls first patients in expandable stent graft trial

January 16, 2024 By Sean Whooley

W.L. Gore & Associates announced today that it enrolled the first patients in a trial evaluating its Viabahn VBX stent graft. The study compares Gore’s balloon-expandable endoprosthesis to bare metal stenting for patients with complex iliac occlusive disease. It aims to inform practice guidelines around the best modalities suited for patients with this condition. Dr. […]

Filed Under: Clinical Trials, Endoscopic, Stent Grafts, Stents, Vascular Tagged With: W.L. Gore & Associates

BD enrolls first patient in study of stent graft for treating portal hypertension

August 10, 2023 By Sean Whooley

BD (NYSE:BDX) announced today that it completed the enrollment of the first patient in a trial of its Liverty TIPS stent graft. Franklin Lakes, New Jersey-based BD’s ARCH FDA investigational device exemption (IDE) study evaluates the safety and effectiveness of Liverty. The global, prospective, multi-center, single-arm clinical study looks at the investigational device in the […]

Filed Under: Cardiovascular, Clinical Trials, Endoscopic, Implants, Stent Grafts, Stents Tagged With: BD

Cook Medical gets FDA nod for endovascular graft trial for treating aortic aneurysm

June 23, 2023 By Sean Whooley

Cook Medical received FDA approval to initiate an investigational device exemption (IDE) study for an aortic aneurysm treatment. The study will evaluate the Zenith Fenestrated + Endovascular Graft (ZFEN+). It assesses the safety and effectiveness of ZFEN+ in combination with Bentley’s InnoMed BeGraft balloon-expandable Fevar bridging stent graft system. The companies aim to look at […]

Filed Under: Clinical Trials, Endoscopic, Food & Drug Administration (FDA), News Well, Regulatory/Compliance, Stent Grafts, Vascular Tagged With: Bentley, Cook Medical, FDA

  • Page 1
  • Page 2
  • Page 3
  • Interim pages omitted …
  • Page 20
  • Go to Next Page »

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy